mTHPC-PLGA-Octreotate nanoparticle conjugate (Nano4therapy)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamemTHPC-PLGA-Octreotate nanoparticle conjugate (Nano4therapy)
Drug Alias Namephotodynamic therapy nanoparticle conjugates(Nano4therapy)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNano4therapy
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNano4therapy
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A